tiprankstipranks
Argent Biopharma (AU:RGT)
ASX:RGT
Australian Market

Argent Biopharma (RGT) Income Statement

Compare
2 Followers

Argent Biopharma Income Statement

Last quarter (Q4 2022), Argent Biopharma's total revenue was $―, a decrease of ― from the same quarter last year. In Q4, Argent Biopharma's net income was $―. See Argent Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 24Jun 23Jun 22Jun 21Jun 20
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 203.70K$ 1.45M$ 1.82M$ 1.31M$ 174.66K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 1.29M$ 751.94K$ 247.69K$ 491.41K$ 481.13K
EBITDA
$ -15.77M$ -20.12M$ ―$ ―$ -18.15M
Operating Income
$ -18.67M$ -15.76M$ -14.25M$ -12.07M$ -11.80M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -17.53M$ -20.82M$ -20.77M$ -15.87M$ -19.36M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Argent Biopharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis